Acute cardiac manifestations under immune checkpoint inhibitors—beware of the obvious: a case report

BACKGROUND: Immune checkpoint inhibitors (ICI) have revolutionized the management of many cancer types by drastically improving the median survival rate of patients. However, this efficiency comes at the cost of a high rate of immune-related adverse events, including lethal cardiac manifestations. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Arangalage, Dimitri, Pavon, Anna Giulia, Özdemir, Berna C, Michielin, Olivier, Schwitter, Jurg, Monney, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Competition Winner
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374985/
https://www.ncbi.nlm.nih.gov/pubmed/34423240
http://dx.doi.org/10.1093/ehjcr/ytab262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374985/
https://www.ncbi.nlm.nih.gov/pubmed/34423240
http://dx.doi.org/10.1093/ehjcr/ytab262

Ejemplares similares